Abstract 4350: Pharmacodynamic biomarker modulation by OMX-0407, a novel, spectrum-selective kinase inhibitor for the treatment of angiosarcoma and renal cell carcinoma - Marisa Stebegg-Wagner; Ilona Petra Maser; Bettina Bauer; Andreas Schirmer; Moritz Zulley; Carmen Amerhauser; Thorsten Meyer; Tiantom Jarutat; Hannes Loferer; Stefan Bissinger (Cancer Research, 2025)